Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

Ontology Browser

Term:
hyperlipoproteinemia type V (DOID:1171)
Annotations: Rat: (1) Mouse: (1) Human: (1) Chinchilla: (1) Bonobo: (1) Dog: (1) Squirrel: (1) Pig: (1)
Parent Terms Term With Siblings Child Terms
cholesterol-ester transfer protein deficiency +   
familial chylomicronemia due to inhibition of lipoprotein lipase activity 
familial chylomicronemia syndrome +   
familial combined hyperlipidemia +   
familial GPIHBP1 deficiency  
familial hypercholesterolemia +   
familial lipoprotein lipase deficiency +   
glycogen storage disease IX +   
Hypercholesterolemia +   
Hyperlipoproteinemia Type II +   
hyperlipoproteinemia type III +   
hyperlipoproteinemia type IV  
hyperlipoproteinemia type V  
A severe type of hyperlipidemia, sometimes familial, that is characterized by the elevation of both plasma CHYLOMICRONS and TRIGLYCERIDES contained in VERY-LOW-DENSITY LIPOPROTEINS. Type V hyperlipoproteinemia is often associated with DIABETES MELLITUS and is not caused by reduced LIPOPROTEIN LIPASE activity as in HYPERLIPOPROTEINEMIA TYPE I .
Hyperlipoproteinemias +   
Hypertriglyceridemia +   
Hypertriglyceridemia, Transient Infantile  
Hypertriglyceridemic Waist 
Lipoprotein Types--Lp System Lp(A) Hyperlipoproteinemia 

Synonyms
Exact Synonyms: Fredrickson type V lipaemia ;   Hyperchylomicronemia Late Onset ;   Hyperchylomicronemia Late Onsets ;   Hyperchylomicronemia With Hyperprebetalipoproteinemia, Familial ;   Hyperlipemia, Combined Fat And Carbohydrate Induced ;   Hyperlipoproteinemia Type 5 ;   Late-Onset Hyperchylomicronemias ;   Mixed Hyperlipemia ;   Mixed Hyperlipemias ;   Type V Hyperlipidemia ;   Type V Hyperlipidemias ;   Type V Hyperlipoproteinemias ;   familial hyperlipoproteinemia type V ;   familial type 5 hyperlipoproteinemia
Primary IDs: MESH:D006954 ;   RDO:0005846
Alternate IDs: OMIM:144650
Xrefs: NCI:C35645
Definition Sources: MESH:D006954

paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.